Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
Evangeline R. Jackson, Ryan J. Duchatel, Dilana E. Staudt, et al.
Cancer Research (2023) Vol. 83, Iss. 14, pp. 2421-2437
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
Vivek Panwar, Aishwarya Singh, Manini Bhatt, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 312
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Cancer Discovery (2023) Vol. 13, Iss. 11, pp. 2370-2393
Open Access | Times Cited: 75
From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress
Brittany Dewdney, Misty R. Jenkins, Sarah A. Best, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 36
CAR T cell therapies for diffuse midline glioma
Bryce C. Thomas, Dilana E. Staudt, Alicia M. Douglas, et al.
Trends in cancer (2023) Vol. 9, Iss. 10, pp. 791-804
Open Access | Times Cited: 18
Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma
Lauren Arms, Ryan J. Duchatel, Evangeline R. Jackson, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 835-865
Open Access | Times Cited: 6
A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-altered
Evangeline R. Jackson, Mika L. Persson, Cameron J Fish, et al.
Neuro-Oncology (2023) Vol. 26, Iss. Supplement_2, pp. S136-S154
Open Access | Times Cited: 14
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort
Yazmín Odia, Matthew D. Hall, Timothy F. Cloughesy, et al.
Neuro-Oncology (2024) Vol. 26, Iss. Supplement_2, pp. S165-S172
Open Access | Times Cited: 4
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer
Andrew D.J. Pearson, Steven G. DuBois, Margaret E. Macy, et al.
European Journal of Cancer (2024) Vol. 207, pp. 114145-114145
Closed Access | Times Cited: 4
Lactylation fuels nucleotide biosynthesis and facilitates deuterium metabolic imaging of tumor proliferation in H3K27M-mutant gliomas
Georgios Batsios, Céline Taglang, Suresh Udutha, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology
Clémence Deligne, Arthur Tourbez, Flavie Bénard, et al.
Neuro-Oncology (2025)
Closed Access
Paediatric Strategy Forum for Medicinal Product Development in Diffuse Midline Gliomas in Children and Adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration
Andrew D.J. Pearson, Sabine Mueller, Mariella G. Filbin, et al.
European Journal of Cancer (2025) Vol. 217, pp. 115230-115230
Open Access
An integrated perspective on single-cell and spatial transcriptomic signatures in high-grade gliomas
C. Lemoine, Marcelo L. da Veiga, Bernard Rogister, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
ONC201-Derived Tetrahydropyridopyrimidindiones as Powerful ClpP Protease Activators to Tackle Diffuse Midline Glioma
Morena Miciaccia, Olga Maria Baldelli, Cosimo G. Fortuna, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Targeted therapy in pediatric central nervous system tumors: a review from the National Pediatric Cancer Foundation
Benjamin I. Siegel, Prabhumallikarjun Patil, Annapoorna Prakash, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Targeted therapy for pediatric glioma: RAF(t)ing in the molecular era
Zhi-Peng Shen, Zhongyuan Zhang, Nan Li, et al.
World Journal of Pediatrics (2025)
Closed Access
ONC206 targeting ClpP induces mitochondrial dysfunction and protective autophagy in hepatocellular carcinoma cells
Jiahao Cao, Fei Cao, Chuanzheng Wang, et al.
Neoplasia (2024) Vol. 55, pp. 101015-101015
Open Access | Times Cited: 3
Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma
Nneka E. Mbah, Amy L. Myers, Peter Sajjakulnukit, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Imipridones and Dopamine Receptor Antagonism in the Therapeutic Management of Gliomas
Eric Burton, Byram H. Ozer, Lisa Boris, et al.
Advances in Oncology (2024) Vol. 4, Iss. 1, pp. 101-110
Closed Access | Times Cited: 2
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study
Vincenzo Di Nunno, Giuseppe Lombardi, Matteo Simonelli, et al.
Journal of Neuro-Oncology (2024) Vol. 167, Iss. 1, pp. 145-154
Closed Access | Times Cited: 2
Just a spoonful of metformin helps the medicine go down
Theophilos Tzaridis, Robert J. Wechsler‐Reya
Journal of Clinical Investigation (2024) Vol. 134, Iss. 6
Open Access | Times Cited: 2
Pediatric diffuse intrinsic pontine glioma radiotherapy response prediction: MRI morphology and T2 intensity-based quantitative analyses
Xiaojun Yu, Shaoqun Li, Wenfeng Mai, et al.
European Radiology (2024) Vol. 34, Iss. 12, pp. 7962-7972
Open Access | Times Cited: 2
Subependymal Giant Cell Astrocytoma: The Molecular Landscape and Treatment Advances
Emanuela Pucko, Dorota Sulejczak, Robert P. Ostrowski
Cancers (2024) Vol. 16, Iss. 19, pp. 3406-3406
Open Access | Times Cited: 2
Targeting Mitochondria in Glioma: New Hopes for a Cure
Lidia Gatto, Vincenzo Di Nunno, Anna Ghelardini, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2730-2730
Open Access | Times Cited: 2
Bridging the age gap: a review of molecularly informed treatments for glioma in adolescents and young adults
Annette Weiser, Astrid Sanchez Bergman, Charbel Machaalani, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Fimepinostat Impairs NF­κB and PI3K/AKT Signaling and Enhances Gemcitabine Efficacy in H3.3K27M-Diffuse Intrinsic Pontine Glioma
Dan Wang, Kun Yan, Hongxing Yu, et al.
Cancer Research (2023) Vol. 84, Iss. 4, pp. 598-615
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top